Menta.li

Company Overview

Snapshot

Founded in August 2025, Menta.li operates with 1–10 employees. The company is currently in its Pre-Funding stage, developing an AI-powered clinical decision support platform for mental health.

Business overview

Menta.li develops LIV, an AI-powered clinical decision support platform designed to enhance mental health assessment, triage, and treatment planning. The platform simulates psychiatric intake sessions, generating structured, DSM-aligned clinical summaries and risk flags to facilitate faster and more accurate diagnoses and care prioritization. Menta.li serves hospitals, HMOs, rehabilitation centers, and government bodies, addressing workforce shortages, standardizing intake quality, and expanding access to timely mental health support for high-stress and trauma-exposed populations. The company operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Medical Decision Support.

Company Intelligence Q&A

What is Menta.li's primary product?

Menta.li's primary product is LIV, an AI-powered clinical decision support platform that simulates psychiatric intake sessions to improve mental health assessment, triage, and treatment planning.

When was Menta.li founded?

Menta.li was founded in August 2025.

What problem does Menta.li aim to solve?

Menta.li aims to address workforce shortages, standardize intake quality, and expand access to timely mental health support for high-stress populations by providing an AI-powered clinical decision support system.

Which sectors does Menta.li operate in?

Menta.li operates in the Health Tech & Life Sciences sector, with a focus on Digital Healthcare and Medical Decision Support.

What is the current product stage of Menta.li's platform?

Menta.li's platform, LIV, is currently in the Beta product stage, as of July 2026. It is being developed with clinicians at Sheba Medical Center.